Arvinas Inc (ARVN)

33.16 +0.92 (+2.85%) USD  |  NASDAQ  |  May 31, 16:00
33.14 -0.02 (-0.06%) After-Hours: 20:00
More

Arvinas Cash from Financing (Quarterly): 1.60M for March 31, 2024

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2018. Upgrade now.
Date Value
March 31, 2024 1.60M
December 31, 2023 334.80M
September 30, 2023 37.90M
June 30, 2023 0.50M
March 31, 2023 1.50M
December 31, 2022 0.50M
September 30, 2022 1.20M
June 30, 2022 0.50M
March 31, 2022 2.50M
December 31, 2021 3.90M
September 30, 2021 266.60M
June 30, 2021 3.60M
March 31, 2021 4.50M
Date Value
December 31, 2020 471.47M
September 30, 2020 30.50M
June 30, 2020 1.279M
March 31, 2020 1.350M
December 31, 2019 108.64M
September 30, 2019 30.75M
June 30, 2019 0.3531M
March 31, 2019 -0.0455M
December 31, 2018 111.11M
September 30, 2018 2.027M
June 30, 2018 -0.0386M
March 31, 2018 54.96M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

0.3531M
Minimum
Jun 2019
471.47M
Maximum
Dec 2020
65.20M
Average
3.05M
Median

Cash from Financing (Quarterly) Benchmarks

Pfizer Inc -4.931B
Bristol-Myers Squibb Co 14.64B
Alnylam Pharmaceuticals Inc 28.91M
Rhythm Pharmaceuticals Inc 4.243M
IDEAYA Biosciences Inc 349.11M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly) -97.50M
Cash from Investing (Quarterly) -127.80M
Free Cash Flow -356.00M
Free Cash Flow Per Share (Quarterly) -1.361
Free Cash Flow to Equity (Quarterly) -97.50M
Free Cash Flow to Firm (Quarterly) -97.60M
Free Cash Flow Yield -17.86%